Itinai.com an advertising light picture for medical analysis 800e68ff 5cb1 4409 8ed4 8cb641b30cf6 1
Itinai.com an advertising light picture for medical analysis 800e68ff 5cb1 4409 8ed4 8cb641b30cf6 1

Front-line and second-line treatment for mantle cell lymphoma in clinical practice: A multicenter retrospective analysis

“`html

Mantle Cell Lymphoma Treatment Patterns and Efficacy

Key Findings:

  • 536 patients with mantle cell lymphoma (MCL) were studied
  • Front-line treatments included high-dose cytarabine, bendamustine, and anthracyclines
  • Median progression-free survival (PFS) for all patients was 45 months
  • Second-line treatments varied, with bendamustine-based regimen being the most common
  • Median second-line PFS was little over 1 year

Practical Solutions and Value:

  • Understanding treatment patterns and efficacy in MCL is crucial for optimizing patient care
  • Front-line treatments showed promising median PFS of over 3.5 years
  • Identification of superior second-line treatment strategies can help improve outcomes for MCL patients

For the full clinical trial report, please visit: Clinical Trial Report

“`

AI-Powered Health Tools

Interactive AI Tools to Help You Understand Your Health

Solutions for Smart Healthcare

Clinical Research